“Anti Il 23 Antibodies”

Abstract: The present invention encompasses isolated antibodies, or antigen-binding portions thereof, that specifically bind to the p19 subunit of IL-23. These antibodies, or antigen-binding portions thereof, are high affinity, neutralizing antibodies useful for the treatment of autoimmune disease.

Patent Information

Application #

Filing Date

21 February 2008

Publication Number

12/2009

Publication Type

INA

Invention Field

BIOTECHNOLOGY

Status

Email

Parent Application

Applicants

ELI LILLY AND COMPANY

Lilly Corporate Center Indianapolis Indiana 46285 USA.

Inventors

1. BEIDLER, Catherine, Brautigam

14057 Painted Desert Road Poway California 92064 US

2. BRIGHT, Stuart, Willis

12408 Brookshire Parkway Carmel Indiana 46033 US

3. DICKINSON, Craig, Duane

15165 Susita Street San Diego California 92129 US

4. KIKLY, Kristine, Kay

6458 North 50 East Fortville Indiana 46040 US

5. MARQUIS, David, Matthew

2106 Meadowgreen Court Encinitas California 92024 US

6. VASSEROT, Alain, Philippe

6421 La Paloma Street Carlsbad California 92009 US

Specification

The present invention is in the field of medicine, particularly in the field of monoclonal antibodies against interleukin ..............

Documents

Application Documents

#	Name	Date
1	1511-DELNP-2008-Correspondence-Others-(22-06-2010).pdf	2010-06-22
1	1511-DELNP-2008_EXAMREPORT.pdf	2016-06-30
2	Form-1.pdf	2011-08-21
2	Form-5.pdf	2011-08-21
3	Form-3.pdf	2011-08-21
4	Form-1.pdf	2011-08-21
4	Form-5.pdf	2011-08-21
5	1511-DELNP-2008-Correspondence-Others-(22-06-2010).pdf	2010-06-22
5	1511-DELNP-2008_EXAMREPORT.pdf	2016-06-30